Cryogenic OGS Limited Reports No Deviation in IPO Fund Utilization for FY26
Published on: April 30, 2026, 3:23 p.m. | Source: scanx.trade
Cryogenic OGS Limited has filed its mandatory fund utilization statement for the half-year ended March 31, 2026, confirming no deviations in the use of ₹17.76 crores raised through its IPO on July 10, 2025. The company has systematically deployed funds across working capital requirements (₹240.12 lakhs utilized from ₹1150.00 lakhs allocated), general corporate purposes (₹284.31 lakhs from ₹396.47 lakhs), and issue expenses (₹228.29 lakhs from ₹230.13 lakhs). The statement, approved by the board and audit committee on April 30, 2026, demonstrates compliance with SEBI regulations and transparent fund management practices.
